Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Vet Med Assoc ; 258(2): 179-185, 2021 Jan 15.
Article in English | MEDLINE | ID: mdl-33405989

ABSTRACT

OBJECTIVE: To investigate the prevalence of pulmonary nodules suggestive of metastasis at the time of initial presentation in dogs with cutaneous or subcutaneous soft tissue sarcomas (STSs) and no previous related thoracic diagnostic imaging. ANIMALS: 146 client-owned dogs with a cutaneous or subcutaneous STS. PROCEDURES: Medical records were retrospectively searched to identify dogs with STSs that underwent initial thoracic diagnostic imaging when presented for referral examination between September 2014 and March 2018. Data collected included patient and tumor characteristics. Results were evaluated for dogs grouped on the basis of variables of interest (eg, STS grade, duration, or history). RESULTS: Initial thoracic imaging was performed with CT (131/146 [89.7%]) or radiography (15 [10.3%]). Although the presence or absence of pulmonary nodules suggestive of metastasis on thoracic imaging was uncertain in 9 dogs, it was certain in the remaining 137 dogs, with nodules present in 16 (11.7%) dogs (5/77 [6%] with grade 1 STSs, 2/36 [6%] with grade 2 STSs, and 9/24 [38%] with grade 3 STSs). The odds of such pulmonary nodules being present on initial examination were higher (OR, 10.8 and 3.14, respectively) for dogs with grade 3 STSs (vs grade 1 or 2 STSs) and for dogs with an STS duration > 3 months (versus ≤ 3 months). CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that pulmonary staging was a low-yield diagnostic procedure for dogs with grade 1 or 2 cutaneous or subcutaneous STSs, especially when tumors had been present for ≤ 3 months.


Subject(s)
Dog Diseases , Sarcoma , Soft Tissue Neoplasms , Administration, Cutaneous , Animals , Dog Diseases/diagnostic imaging , Dog Diseases/epidemiology , Dogs , Prevalence , Retrospective Studies , Sarcoma/epidemiology , Sarcoma/veterinary , Soft Tissue Neoplasms/epidemiology , Soft Tissue Neoplasms/veterinary
2.
J Am Vet Med Assoc ; 240(4): 446-9, 2012 Feb 15.
Article in English | MEDLINE | ID: mdl-22309017

ABSTRACT

CASE DESCRIPTION: A 12-year-old neutered male Springer Spaniel was referred with a 1-year history of recurring urinary tract infections. Repeated treatment with appropriate antimicrobials selected on the basis of bacterial culture and antimicrobial susceptibility results would result in clinical improvement, but recurrence of clinical signs was observed within days after discontinuation of treatment. CLINICAL FINDINGS: Ultrasound examination revealed a tubular, fluid-filled structure dorsal to the bladder that extended from the midlevel of the bladder to the cranial pole of the prostate. Mineralized foci within a heterogeneous prostatic parenchyma were also noted. Dilation of the right ductus deferens (DD) was observed during exploratory laparotomy. TREATMENT AND OUTCOME: Both DD were surgically removed, and the prostate was biopsied. The histopathological diagnosis was transitional cell carcinoma involving the right DD and the prostate. The dog was treated with meloxicam (0.1 mg/kg [0.05 mg/lb], p.o., q 24 h) for 9 months after diagnosis before being euthanized. CLINICAL RELEVANCE: Because the normal DD is rarely visualized during abdominal ultrasonography in dogs, identification of a tubular, fluid-filled structure dorsal to the bladder may indicate an abnormal DD. Transitional cell carcinoma of the DD should be included in the differential diagnoses of affected patients examined for clinical signs involving the urinary tract.


Subject(s)
Carcinoma, Transitional Cell/veterinary , Dog Diseases/diagnosis , Prostatic Neoplasms/veterinary , Testicular Neoplasms/veterinary , Vas Deferens , Animals , Carcinoma, Transitional Cell/diagnosis , Carcinoma, Transitional Cell/drug therapy , Cyclooxygenase Inhibitors/therapeutic use , Dog Diseases/drug therapy , Dogs , Euthanasia, Animal , Male , Meloxicam , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/drug therapy , Testicular Neoplasms/diagnosis , Testicular Neoplasms/drug therapy , Thiazines/therapeutic use , Thiazoles/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...